PCN209 - A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) (Checkmate 141)

Autor:	Simpson, S¹, Cocks, K¹, Contente, M², DeRosa, M³, Taylor, F³, Shaw, JW⁴
Zdroj:	Value in Health. Oct2017, Vol. 20 Issue 9, pA450-A450. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect